
Principles of prevention and management of adverse events of immunomodulatory drugs in the treatment of multiple myeloma
Author(s) -
Grzegorz Charliński,
David H. Vesole,
Artur Jurczyszyn
Publication year - 2022
Publication title -
nowotwory
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.115
H-Index - 8
eISSN - 2300-2115
pISSN - 0029-540X
DOI - 10.5603/njo.a2022.0031
Subject(s) - thalidomide , pomalidomide , lenalidomide , multiple myeloma , cereblon , medicine , adverse effect , pharmacology , safety profile , ubiquitin ligase , chemistry , biochemistry , ubiquitin , gene